Hikma Pharmaceuticals Plc Director/PDMR Shareholding (3051A)
March 23 2017 - 4:30AM
UK Regulatory
TIDMHIK
RNS Number : 3051A
Hikma Pharmaceuticals Plc
23 March 2017
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
The attached individual notification made under article 19.1 of
the Market Abuse Regulation ("MAR") relates to the disposal of
Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by
the Chief Strategy and Corporate Development Officer. This
announcement is made in accordance with article 19.3 of MAR.
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------------
a) Name Bassam Kanaan
--- --------------------- -------------------------------------------
2 Reason for the notification
--- ------------------------------------------------------------------
a) Position/status Chief Strategy and Corporate Development
Officer / PDMR
--- --------------------- -------------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- -------------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- -------------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- -------------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ------------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- -------------------------------------------
b) Nature of Disposal of 43,000 Ordinary Shares
the transaction of 10 pence each in Hikma Pharmaceuticals
PLC.
--- --------------------- -------------------------------------------
c) Price(s) and Price(s): GBP21.22
volume(s) Volume(s): 43,000
--- --------------------- -------------------------------------------
d) Aggregated Aggregated volume: 43,000
information Price: GBP21.22
--- --------------------- -------------------------------------------
e) Date of the 20 to 22 March 2017
transaction
--- --------------------- -------------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
--- --------------------- -------------------------------------------
Peter Speirs, Company Secretary, Responsible for releasing this
announcement
23 March 2017
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGCGDXCDDBGRX
(END) Dow Jones Newswires
March 23, 2017 05:30 ET (09:30 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024